Oman- NPI issues statement over recall of Omafen tablets

3/9/2016 6:49:07 AM

(MENAFN- Muscat Daily) Muscat-

National Pharmaceutical Industries (NPI) has issued a statement following an official circular recalling Omafen tablets due to the presence of aluminium pieces.

A statement by the company read 'In reference to recent news articles and media reports citing circular No 11/2016 issued by the Directorate General of Pharmaceutical Affairs and Drug Control at the Ministry of Health regarding the recall of Omafen tablets wherein there is an impression that aluminium pieces are present in the tablet National Pharmaceutical Industries (NPI) would like to clarify that there is no aluminium pieces present in the tablet.'

It added 'In isolated cases a piece of aluminium packing foil was found in a blister cavity. As part of NPI's commitment to safety and quality Omafen tablets from specific batches were recalled from the market in close coordination with the Ministry of Health.'

The company's communique stated that all its equipment facilities and products in addition to cleaning procedures are completely validated and documented.

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.